We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pozen Wins Injunction On Generic Treximet

Law360, San Diego (August 8, 2011, 4:17 PM EDT) -- A Texas federal judge ruled Friday that Par Pharmaceutical Cos. Inc. and two other drugmakers had infringed Pozen Inc.'s patents covering the migraine treatment Treximet and barred them from selling generic...
To view the full article, register now.